Ann: 2016 Annual Report-OBJ.AX, page-6

I have mixed views about this report:
- is a bit early - why?????? Something else in the horizon?
- it's largely waffly about current progress (more can be gleaned from previous announcements)
- I liked the reference to Coty getting FDA approval to market the device (it's not "medical") - that suggests they're almost ready to launch
- WTF happened to Kevin Hammond and the U.K. Division of OBJ?!! He's been "terminated" and the U.K. Subsidiary of OBJ wound up! When
And why did this happen????
- body guard info was a regurgitation of all that's already been reported.

In conclusion, a pretty mediocre report in terms of new info. References to "discussions" and "progressing" we've seen all before. A few new names thrown in this year s report -
Pfizer gets its own sub-heading! - but nothing of substance yet.

Positive, but a real case of "slow and steady wins the race".